+1 7178835943 [email protected]
Hybrid Event (In-person or Virtual participation)

International Conference on Vaccines, Infectious Diseases and Immunological Research · Registering as Listener

ICVIDIR
📅 4 – 5 Mar 2027 📍 Birmingham, UK 👥 Standard / Physical Participation
Listener Registration From
$185
Registration Benefits:
Official invitation letterIssued automatically after registration
🎖 Certificate & digital materialsGet certificate, slides and resource materials
🌐 Supporting global researchConnect with researchers across 30+ countries

Select registration mode

Prices are shown before tax and bank charges — no surprises at checkout.

All sessions Networking Certificate Invitation letter Conference kit

Your details

We only need what's required to register and email your confirmation. Everything else is optional.

Coupon Code (If Any)

Have a code? Apply it here — the discount updates the total immediately.

🏷

For Support Please Contact

VISAMASTERCARDNET BANKINGUPI

Payments encrypted & processed securely. Refundable up to 14 days before the event.

Registration summary

ConferenceInternational Conference on Vaccines, Infectious Diseases and Immunological Research
ModeStandard / Physical
ParticipationListener
Registration fee$185.00
Bank charges (5.8%)$10.73
Total payable $195.73

Includes all bank processing charges — the amount above is exactly what will be charged.

Need help?

Contact our registration team:

📞 +91 93445 35349

Benefits of Registering as Listener

👥Access to Conference Sessions
🔗Networking Opportunities
🎖Certificate of Participation
Invitation Letter Support
📚Conference Kit / Materials
🎤Access to Keynote Sessions
• Conference Session Tracks •
SDG

SDG-Aligned Research Themes

Conference tracks support global knowledge exchange, innovation, and sustainable development priorities across diverse disciplines.

SDG 3 SDG 4 SDG 9 SDG 16

This track focuses on the latest innovations in vaccine technology, including novel adjuvants and delivery systems. Researchers will present findings on the efficacy and safety of new vaccine candidates against various infectious diseases.

This session will explore the underlying immunological responses to infectious agents, highlighting the role of innate and adaptive immunity. Presentations will cover mechanisms of immune evasion by pathogens and implications for vaccine design.

This track will discuss the design, implementation, and outcomes of clinical trials for new vaccines. Attendees will gain insights into regulatory challenges and the importance of diverse populations in trial participation.

This session will delve into the biology of pathogens and their interactions with the host immune system. Research presented will include studies on virulence factors and their impact on disease progression.

This track will examine strategies for controlling infectious disease outbreaks, including vaccination campaigns and public health interventions. Case studies will highlight successful responses to recent outbreaks.

This session will focus on the role of immunotherapy in treating infectious diseases, including monoclonal antibodies and immune checkpoint inhibitors. Discussions will cover current research and future directions in this emerging field.

This track will address the challenges of vaccine hesitancy and its impact on public health. Researchers will present studies on factors influencing vaccine acceptance and strategies to improve public perception.

This session will focus on the emergence of new infectious diseases and their implications for global health security. Presentations will include surveillance strategies and the role of international collaboration in outbreak response.

This track will explore innovative strategies for disease prevention beyond vaccination, including behavioral interventions and public health policies. Research will highlight the importance of a multidisciplinary approach to health promotion.

This session will discuss the importance of vaccine safety monitoring and pharmacovigilance in ensuring public trust. Presentations will cover methodologies for assessing vaccine safety and reporting adverse events.

This track will highlight the significance of international partnerships in advancing vaccine research and development. Discussions will focus on collaborative efforts to address global health challenges and share resources.

COPYRIGHT © 2026 ISAR. ALL RIGHTS RESERVED